Correlation Between Bank of America and Arch Therapeutics
Can any of the company-specific risk be diversified away by investing in both Bank of America and Arch Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank of America and Arch Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bank of America and Arch Therapeutics, you can compare the effects of market volatilities on Bank of America and Arch Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank of America with a short position of Arch Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank of America and Arch Therapeutics.
Diversification Opportunities for Bank of America and Arch Therapeutics
-0.77 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Bank and Arch is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding Bank of America and Arch Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arch Therapeutics and Bank of America is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank of America are associated (or correlated) with Arch Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arch Therapeutics has no effect on the direction of Bank of America i.e., Bank of America and Arch Therapeutics go up and down completely randomly.
Pair Corralation between Bank of America and Arch Therapeutics
Considering the 90-day investment horizon Bank of America is expected to generate 0.19 times more return on investment than Arch Therapeutics. However, Bank of America is 5.35 times less risky than Arch Therapeutics. It trades about 0.35 of its potential returns per unit of risk. Arch Therapeutics is currently generating about -0.18 per unit of risk. If you would invest 4,133 in Bank of America on September 3, 2024 and sell it today you would earn a total of 618.00 from holding Bank of America or generate 14.95% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bank of America vs. Arch Therapeutics
Performance |
| Timeline |
| Bank of America |
| Arch Therapeutics |
Bank of America and Arch Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bank of America and Arch Therapeutics
The main advantage of trading using opposite Bank of America and Arch Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank of America position performs unexpectedly, Arch Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arch Therapeutics will offset losses from the drop in Arch Therapeutics' long position.| Bank of America vs. Partner Communications | Bank of America vs. Merck Company | Bank of America vs. Western Midstream Partners | Bank of America vs. Edgewise Therapeutics |
| Arch Therapeutics vs. biOasis Technologies | Arch Therapeutics vs. Antibe Therapeutics | Arch Therapeutics vs. Awakn Life Sciences | Arch Therapeutics vs. Cellectis SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |